CellSeed Inc. Logo

CellSeed Inc.

Develops cell sheet products, culture equipment, and offers contract manufacturing services.

7776 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
江東区青海2−5−10テレコムセンタービル15F
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CellSeed Inc. is a regenerative medicine company focused on the commercialization of its proprietary 'cell sheet engineering' technology, an innovative therapeutic approach originating in Japan. The company's core business involves the research, development, and manufacturing of cell sheet-based products to treat diseases and disorders. In addition to its therapeutic pipeline, CellSeed develops and sells specialized cell culture equipment and provides contracted development and manufacturing services for cell sheets. The company aims to deliver its novel medical treatments to patients globally, leveraging its expertise in cell culture and production to advance the field of regenerative medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:48
Report Publication Announcement
確認書
Japanese 8.0 KB
2025-08-14 08:47
Interim Report
半期報告書-第25期(2025/01/01-2025/12/31)
Japanese 176.2 KB
2025-03-27 06:07
Post-Annual General Meeting Information
臨時報告書
Japanese 25.6 KB
2025-03-26 08:00
Registration Form
確認書
Japanese 8.1 KB
2025-03-26 08:00
Governance Information
内部統制報告書-第24期(2024/01/01-2024/12/31)
Japanese 21.2 KB
2025-03-26 07:59
Annual Report
有価証券報告書-第24期(2024/01/01-2024/12/31)
Japanese 827.2 KB
2024-08-14 08:15
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-08-14 08:14
Interim Report
半期報告書-第24期(2024/01/01-2024/06/30)
Japanese 181.4 KB
2024-05-15 08:19
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-05-15 08:19
Quarterly Report
四半期報告書-第24期第1四半期(2024/01/01-2024/03/31)
Japanese 145.1 KB
2024-03-28 07:11
Post-Annual General Meeting Information
臨時報告書
Japanese 22.0 KB
2024-03-28 07:08
Registration Form
確認書
Japanese 8.1 KB
2024-03-28 07:07
Governance Information
内部統制報告書-第23期(2023/01/01-2023/12/31)
Japanese 22.2 KB
2024-03-28 07:04
Annual Report
有価証券報告書-第23期(2023/01/01-2023/12/31)
Japanese 875.2 KB
2023-11-14 08:37
Regulatory News Service
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all CellSeed Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CellSeed Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SEYİTLER KİMYA SANAYİ A.Ş. Logo
Manufacturer of medical tapes, wound dressings, and first aid plasters for the healthcare industry.
Türkiye SEYKM
Shaperon Inc. Logo
Develops inflammasome inhibitors & nanobodies for inflammatory diseases and cancer.
South Korea 378800
Shedir Pharma Group Logo
Develops and sells pharmaceutical, nutraceutical, and dermo-cosmetic products in Italy & Spain.
Italy SHE
SHIELD THERAPEUTICS PLC Logo
Commercializing a novel oral therapy for adults with iron deficiency.
United Kingdom STX
SHINPOONG PHARMACEUTICAL CO.,LTD Logo
R&D-driven pharma firm making APIs, finished drugs, and medical products for global markets.
South Korea 019170
Shionogi & Co.,Ltd. Logo
A research-driven pharmaceutical firm creating drugs, diagnostics, and devices for global health.
Japan 4507
Siegfried Holding AG Logo
Global CDMO providing development and manufacturing of APIs and finished drugs for the pharma industry.
Switzerland SFZN
Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.
South Korea 215600
SK biopharmaceuticals Co., Ltd. Logo
Develops and commercializes CNS and oncology therapies for global markets, focusing on the U.S.
South Korea 326030
SK Bioscience Co.,Ltd Logo
A global biotech firm developing vaccines for diseases like COVID-19, influenza, and shingles.
South Korea 302440

Talk to a Data Expert

Have a question? We'll get back to you promptly.